NCT01724788View on ClinicalTrials.gov

Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Renal Failure
Interventions
DRUG

FUROSEMIDE

Pharmaceutical form: Solution Route of administration: Intravenous

DRUG

FUROSEMIDE (HOE058)

Pharmaceutical form: Tablet Route of administration: Oral

Trial Locations (1)

H1T 2M4

Investigational Site Number 124002, Montreal

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY